Where does TransEnterix Europe S.a.r.l. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), TransEnterix Europe S.a.r.l. ranks #23,567 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does TransEnterix Europe S.a.r.l. hold?

TransEnterix Europe S.a.r.l. holds 12 US utility patents granted between 2019 and 2021, spanning 9 technology areas.

What is TransEnterix Europe S.a.r.l.'s Innovation Score?

TransEnterix Europe S.a.r.l. has an Innovation Score of 30.9 out of 100 (36th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does TransEnterix Europe S.a.r.l. focus on?

TransEnterix Europe S.a.r.l.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 12 patents, ranking #1,451 of 7,127 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is TransEnterix Europe S.a.r.l.'s patent grant rate increasing or decreasing?

TransEnterix Europe S.a.r.l.'s recent grant velocity is +40% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for TransEnterix Europe S.a.r.l.'s patents?

TransEnterix Europe S.a.r.l.'s patents average 19.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the TransEnterix Europe S.a.r.l. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

TransEnterix Europe S.a.r.l.

USPTO PatentsView assignee record - 12 granted patents across 9 technology areas, recorded in grant years 2019–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Transenterix ranks #23,567 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 9 technology areas.

#23,567
of 49,997 US assignees by volume: 36th percentile
by Innovation Score (30.9/100): 19.0
avg claims per patent: +40%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R23567 · Foreign Corporation #23,567 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-MICRO 12 grants
MID-PACK #23,567/49,997
PHOTO-FINISH Totum Labs
CPC-NARROW A61B · 9 areas
INNOV-THIN 30.9/100
CLAIMS-RICH 19.0 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +40% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Totum Labs, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Transenterix’s 30.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.9 pts (29%) Velocity 0.0 pts (0%) Breadth 10.6 pts (34%) Claim depth 11.4 pts (37%)

Qualcomm Incorporated · highest

85
TransEnterix Europe… · this assignee

31
3D Lighting… · lowest

7

What this shows Transenterix's Innovation Score is 30.9/100 (36th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Transenterix?

Each dot is one of Transenterix’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Transenterix’s own 19.0 claims/patent is ABOVE the 15.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Transenterix vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Transenterix's grants concentrate

TransEnterix Europe S.a.r.l. is a focused PatentsView assignee: 9 CPC subclasses with 100% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2019 (5 grants) versus a trough of 2 in 2021. By volume, Transenterix sits between Totum Labs, Inc. and Turingsense Inc..

Totum Labs

12
Townsteel

12
Tracelink

12
Trade Fixtures

12
Transit Scientific

12
Truck Shields

12
True Concepts Med…

12
Turingsense

12
Transenterix Euro… ◀

12

What this shows TransEnterix holds 12 patents at rank #23,568, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near TransEnterix

By rank, the assignees closest to #23,568 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in TransEnterix's primary technology class.

Transenterix's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

31 36th percentile higher than 36% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

TransEnterix Europe S.a.r.l. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	5	41.7%
2020	5	41.7%
2021	2	16.7%

Which technologies does TransEnterix Europe S.a.r.l. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 12

G08C - Transmission Systems FOR Measured Values, Control OR Similar Signals 2

G05B - Control OR Regulating Systems IN GENERAL; Functional Elements OF Such SYSTEMS; Monitoring OR Testing Arrangements FOR Such Systems OR Elements 2

H04N - Pictorial Communication, e.g. Television 1

G02B - Optical Elements, Systems OR Apparatus 1

G06F - Electric Digital Data Processing 1

A41D - OUTERWEAR; Protective GARMENTS; Accessories 1

G10L - Speech Analysis Techniques OR Speech SYNTHESIS; Speech RECOGNITION; Speech OR Voice Processing TECHNIQUES; Speech OR Audio Coding OR Decoding 1

B25J - MANIPULATORS; Chambers Provided With Manipulation Devices 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

TransEnterix Europe S.a.r.l.'s patent record in context - here's where to go next.

TransEnterix Europe S.a.r.l.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 100% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #23,567 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare TransEnterix Europe S.a.r.l. against Totum Labs, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 30.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.